Cargando…

A phase 2, proof of concept, randomised controlled trial of berberine ursodeoxycholate in patients with presumed non-alcoholic steatohepatitis and type 2 diabetes

Non-alcoholic steatohepatitis is frequently associated with diabetes and may cause progressive liver disease. Current treatment options are limited. Here we report on a prospective, randomised, double-blind, placebo-controlled trial of two doses of HTD1801 (berberine ursodeoxycholate, an ionic salt...

Descripción completa

Detalles Bibliográficos
Autores principales:	Harrison, Stephen A., Gunn, Nadege, Neff, Guy W., Kohli, Anita, Liu, Liping, Flyer, Abbey, Goldkind, Lawrence, Di Bisceglie, Adrian M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8448729/ https://www.ncbi.nlm.nih.gov/pubmed/34535644 http://dx.doi.org/10.1038/s41467-021-25701-5

Ejemplares similares

Pharmacokinetics and pharmacodynamics of HTD1801 (berberine ursodeoxycholate, BUDCA) in patients with hyperlipidemia
por: Di Bisceglie, Adrian M., et al.
Publicado: (2020)

The role of Ursodeoxycholic acid in non-alcoholic steatohepatitis: a systematic review
por: Xiang, Zun, et al.
Publicado: (2013)

Structure of proof of concept studies that precede a nonalcoholic steatohepatitis development program
por: Williams, RN, et al.
Publicado: (2016)

Berberine Reduces Neurotoxicity Related to Nonalcoholic Steatohepatitis in Rats
por: Ghareeb, Doaa A., et al.
Publicado: (2015)

Berberine ameliorates non-alcoholic steatohepatitis in ApoE(−/−) mice
por: Yang, Jin, et al.
Publicado: (2017)

Spirulina Liquid Extract Protects against Fibrosis Related to Non-Alcoholic Steatohepatitis and Increases Ursodeoxycholic Acid
por: Coué, Marine, et al.
Publicado: (2019)

ASC, IL-18 and Galectin-3 as Biomarkers of Non-Alcoholic Steatohepatitis: A Proof of Concept Study
por: Cyr, Brianna, et al.
Publicado: (2020)

Gut microbiota profile in patients with nonalcoholic fatty liver disease and presumed nonalcoholic steatohepatitis
por: Mohammadi, Zahra, et al.
Publicado: (2022)

Berberine Prevents Disease Progression of Nonalcoholic Steatohepatitis through Modulating Multiple Pathways
por: Wang, Yanyan, et al.
Publicado: (2021)

Presuming consent in the ethics of posthumous sperm procurement and conception
por: Kroon, Frederick
Publicado: (2016)

Omega-3 polyunsaturated fatty acid and ursodeoxycholic acid have an additive effect in attenuating diet-induced nonalcoholic steatohepatitis in mice
por: Kim, Ja Kyung, et al.
Publicado: (2014)

Berberine prevents progression from hepatic steatosis to steatohepatitis and fibrosis by reducing endoplasmic reticulum stress
por: Zhang, Zhiguo, et al.
Publicado: (2016)

Biological synthesis of ursodeoxycholic acid
por: Song, Peng, et al.
Publicado: (2023)

Metabolomics Profiling to Investigate the Pharmacologic Mechanisms of Berberine for the Treatment of High-Fat Diet-Induced Nonalcoholic Steatohepatitis
por: Li, Jian, et al.
Publicado: (2015)

Berberine Alleviates Non-alcoholic Steatohepatitis Through Modulating Gut Microbiota Mediated Intestinal FXR Activation
por: Shu, Xiangbing, et al.
Publicado: (2021)

Effect of Ursodeoxycholic Acid Alone and Ursodeoxycholic Acid Plus Domperidone on Radiolucent Gallstones and Gallbladder Contractility in Humans
por: Tuncer, Ilyas, et al.
Publicado: (2012)

Mobility-Related Gaze Training in Individuals With Glaucoma: A Proof-of-Concept Study
por: Gunn, Shaila M., et al.
Publicado: (2019)

Direct Synthesis of Mesoporous Organosilica and Proof-of-Concept Applications in Lysozyme Adsorption and Supported Catalysis
por: Osta, Oriana, et al.
Publicado: (2020)

Hospital Production of Sterile 2% Propofol Nanoemulsion: Proof of Concept
por: Cèbe, Amélie, et al.
Publicado: (2023)

The Conservative Management of Choledocholithiasis With Ursodeoxycholic Acid
por: Oluboyede, Daniel O, et al.
Publicado: (2023)

What is presumed when we presume consent?
por: Pierscionek, Barbara K
Publicado: (2008)

Molecular Mechanisms of Ursodeoxycholic Acid Toxicity & Side Effects: Ursodeoxycholic Acid Freezes Regeneration & Induces Hibernation Mode
por: Kotb, Magd A.
Publicado: (2012)

The Versatile Transceiver Proof of Concept
por: Troska, J, et al.
Publicado: (2009)

Influence of the Bile Acid Transporter Genes ABCB4, ABCB8, and ABCB11 and the Farnesoid X Receptor on the Response to Ursodeoxycholic Acid in Patients with Nonalcoholic Steatohepatitis
por: Kreimeyer, Henriette, et al.
Publicado: (2023)

Strengthening Government Leadership in Family Planning Programming in Senegal: From Proof of Concept to Proof of Implementation in 2 Districts
por: Aichatou, Barry, et al.
Publicado: (2016)

Kinesthetic stimulation for obstructive sleep apnea syndrome: An “on-off” proof of concept trial
por: Hernández, Alfredo I., et al.
Publicado: (2018)

Ursodeoxycholic acid production by Gibberella zeae mutants
por: Kollerov, Vyacheslav, et al.
Publicado: (2022)

Presumed osteosarcoma
por: Kettritz, Ralph, et al.
Publicado: (2013)

The LHCb Grid simulation: Proof of concept
por: Hushchyn, M, et al.
Publicado: (2017)

DNA watermarks: A proof of concept
por: Heider, Dominik, et al.
Publicado: (2008)

Groupness in Preverbal Infants: Proof of Concept
por: Bradley, Benjamin Sylvester, et al.
Publicado: (2017)

A decline of LAMP- 2 predicts ursodeoxycholic acid response in primary biliary cirrhosis
por: Wang, Lu, et al.
Publicado: (2015)

Ursodeoxycholic Acid Protects Against Arsenic Induced Hepatotoxicity by the Nrf2 Signaling Pathway
por: Li, Chao, et al.
Publicado: (2020)

Increased circulating butyrate and ursodeoxycholate during probiotic intervention in humans with type 2 diabetes
por: McMurdie, Paul J., et al.
Publicado: (2022)

The Impact of an SGLT2 Inhibitor versus Ursodeoxycholic Acid on Liver Steatosis in Diabetic Patients
por: Elhini, Sahar H., et al.
Publicado: (2022)

Dihydroartemisinin-Ursodeoxycholic Bile Acid Hybrids in the Fight against SARS-CoV-2
por: Marchesi, Elena, et al.
Publicado: (2023)

Clinical diagnosis of presumed SOX2 gonadosomatic mosaicism
por: Varela, Malena Daich, et al.
Publicado: (2021)

SDR Proof-of-Concept of Full-Duplex Jamming for Enhanced Physical Layer Security
por: Silva, André, et al.
Publicado: (2021)

Incretin secretion stimulated by ursodeoxycholic acid in healthy subjects
por: Murakami, Masanori, et al.
Publicado: (2013)

Improvements of Fibrosis and Disease Activity Are Associated With Improvement of Patient‐Reported Outcomes in Patients With Advanced Fibrosis Due to Nonalcoholic Steatohepatitis
por: Younossi, Zobair M., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_nk50t2cqevs5i3maan2ll7ihdj